Holen Sie sich die Stockscreener-App
6.66
2.63%
-0.18
Schlusskurs vom Vortag:
$6.84
Offen:
$6.7
24-Stunden-Volumen:
589
Relative Volume:
0.02
Marktkapitalisierung:
$92.38M
Einnahmen:
$49.98M
Nettoeinkommen (Verlust:
$-9.64M
KGV:
-9.3803
EPS:
-0.71
Netto-Cashflow:
$-4.86M
1W Leistung:
-2.35%
1M Leistung:
+5.71%
6M Leistung:
+15.42%
1J Leistung:
+66.50%
1-Tages-Spanne:
$6.70
$6.70
1-Wochen-Bereich:
$6.67
$6.90
52-Wochen-Spanne:
$3.955
$11.99
Champions Oncology Inc Stock (CSBR) Company Profile
Firmenname
Champions Oncology Inc
Sektor
Branche
Telefon
410-369-0365
Adresse
855 N. WOLFE STREET, BALTIMORE, NJ
Vergleichen Sie CSBR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CSBR
Champions Oncology Inc
|
6.70 | 94.31M | 49.98M | -9.64M | -4.86M | -0.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.15 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
643.64 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
445.88 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
829.21 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.06 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Champions Oncology Inc Stock (CSBR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-09-12 | Hochstufung | Craig Hallum | Hold → Buy |
| 2019-11-18 | Eingeleitet | The Benchmark Company | Speculative Buy |
Champions Oncology Inc Aktie (CSBR) Neueste Nachrichten
What indicators show strength in Champions Oncology Inc.Swing Trade & Reliable Volume Spike Alerts - newser.com
Real time social sentiment graph for Champions Oncology Inc.2025 Major Catalysts & Safe Capital Growth Plans - newser.com
Why Champions Oncology Inc. (2I3) stock could rally stronglyMarket Activity Recap & Real-Time Stock Entry Alerts - newser.com
Candlestick signals on Champions Oncology Inc. stock todayWeekly Trend Summary & Consistent Growth Equity Picks - newser.com
What earnings margins imply for Champions Oncology Inc. (2I3) stockJuly 2025 Outlook & Long Hold Capital Preservation Plans - newser.com
Why analysts recommend Champions Oncology Inc. (2I3) stockMarket Sentiment Report & Verified Swing Trading Watchlist - newser.com
Will Champions Oncology Inc. (2I3) stock test record highs in 2025Earnings Miss & Breakout Confirmation Alerts - newser.com
Published on: 2025-11-02 03:57:30 - newser.com
Why Champions Oncology Inc. is moving todayJuly 2025 PostEarnings & Weekly Chart Analysis and Guides - newser.com
Why pension funds invest in Champions Oncology Inc. (2I3) stockJuly 2025 Sector Moves & Reliable Entry Point Alerts - newser.com
Champions Oncology Inc 2I3 Stock Analysis and ForecastIndustrial Stocks Review & Consistent Double Returns - earlytimes.in
How Champions Oncology Inc. stock benefits from strong dollar2025 Stock Rankings & Growth Oriented Trading Recommendations - newser.com
Tick level data insight on Champions Oncology Inc. volatility2025 Retail Activity & Low Risk Entry Point Tips - newser.com
Is Champions Oncology Inc. showing signs of accumulationWeekly Trade Analysis & Stock Portfolio Risk Management - newser.com
Will Champions Oncology Inc. continue its uptrendJuly 2025 Sector Moves & Verified Short-Term Plans - newser.com
Published on: 2025-10-30 22:50:51 - newser.com
What Wall Street predicts for Champions Oncology Inc. stock priceJuly 2025 Snapshot & Low Drawdown Trading Techniques - fcp.pa.gov.br
What momentum indicators show for Champions Oncology Inc. stockTrade Entry Summary & Proven Capital Preservation Tips - Fundação Cultural do Pará
Finanzdaten der Champions Oncology Inc-Aktie (CSBR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.09%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):